192 results
6-K
EX-99.1
IPHA
Innate Pharma
7 May 24
Innate Pharma announces conference call and webcast for Q1 2024 business update
6:03am
in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies
6-K
EX-99.1
IPHA
Innate Pharma
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
leukemia. Efficacy and safety results from the dose-escalation part of the trial were shared in a poster presentation at the American Society … inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical
6-K
EX-99.1
IPHA
Innate Pharma
15 Apr 24
Current report (foreign)
6:00am
related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory
6-K
EX-99.1
IPHA
Innate Pharma
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
. In addition, IPH45 has an additive anti-tumor effect to anti-PD1 treatment in vivo and has a favorable safety profile in relevant animal toxicology models … in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical
6-K
EX-99.1
a76e5 9dfblh
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
6-K
EX-99.1
cxmfy
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
EX-99.1
bomj2o
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
EX-99.1
fcwi81z1up9
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
EX-99.01
0m7o3cnhy
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.01
22wuk7
6 Mar 24
Current report (foreign)
6:00am
6-K
EX-99.1
7ck8n
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
EX-1.1
ig9llx996
6 Feb 24
Current report (foreign)
5:05pm
6-K
EX-99.1
upoxrgdsek9 rt9r73ge
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
q0ikzbz4i98wqhpgms
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
6-K
EX-99.1
kiy3mwppb1s9
4 Jan 24
Innate Pharma 6-K
6:00am
6-K
EX-99.1
nrc 8kqbajj6qimzk
20 Dec 23
Current report (foreign)
4:30pm
6-K
EX-99.1
pvtmelo6kkon98rke
19 Dec 23
Innate Pharma S.a. 6-K
6:00am
6-K
EX-99.1
vzlr42g
18 Dec 23
Innate Pharma S.a. 6-K
11:40am